Parkinsons Disease (PD) is a progressive neurodegenerative disorder which significantly affects motor function, daily coordination and verbal communication. Speech-based biomarkers provide a non-invasive and scalable approach to early detection, as dysphonia is one of the earliest and most consistent clinical markers of PD. The dataset used in this study is publicly available and consists of 756 voice recordings from 252 subjects (188 with PD and 64 neurologically healthy controls) with a wide range of acoustic parameters such as Mel-Frequency Cepstral Coefficients (MFCCs), energy-based parame